Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

S F Jørgensen; M E Macpherson; T Bjørnetrø; K Holm; M Kummen; A Rashidi; A E Michelsen; T Lekva; B Halvorsen; M Trøseid; T E Mollnes; R K Berge; A Yndestad; T Ueland; T H Karlsen; P Aukrust; J R Hov; B Fevang

doi:10.1038/s41598-024-54117-6

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Sci Rep. 2024 Feb 14;14(1):3704. doi: 10.1038/s41598-024-54117-6.

Authors

S F Jørgensen^{1

2

3}, M E Macpherson^{4

5

6}, T Bjørnetrø^{4

7}, K Holm^{4

6

7}, M Kummen^{4

7}, A Rashidi⁴, A E Michelsen^{4

6}, T Lekva⁴, B Halvorsen^{4

6}, M Trøseid^{4

5

6}, T E Mollnes^{8

9

10}, R K Berge^{11

12}, A Yndestad^{4

6}, T Ueland^{4

6}, T H Karlsen^{4

6

7}, P Aukrust^{4

5

6}, J R Hov^#^{4

6

7}, B Fevang^#^{4

5}

Affiliations

¹ Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway. [email protected].
² Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway. [email protected].
³ Institute of Clinical Medicine, University of Oslo, Oslo, Norway. [email protected].
⁴ Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
⁵ Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway.
⁶ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁷ Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.
⁸ Research Laboratory, Nordland Hospital, Bodø, and Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway.
⁹ Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.
¹⁰ Department of Immunology, Oslo University Hospital, and University of Oslo, Oslo, Norway.
¹¹ Department of Clinical Science, University of Bergen, Bergen, Norway.
¹² Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.

^# Contributed equally.

No abstract available

Publication types

Retraction of Publication